A review of the current status of endoluminal therapy as a primary approach to obesity management

Shounak Majumder, John Birk

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Gastroenterologists are expected to play a pivotal role in the management of the global obesity epidemic in coming years as novel endoscopic approaches become more widely available, safe, and effective. This review focuses on the recent advances in the field of endoluminal therapy as a primary approach to obesity management with the aim of providing the interventional endoscopist an overview of currently available evidence along with an insight into upcoming devices and techniques. The intragastric balloon appears to be safe and effective in the short term, especially as a bridge to bariatric surgery. Although early trials support the safety and feasibility of endoscopic gastroplasty, it is technically demanding and staple-line dehiscence continues to be a problem. Moreover, with ongoing technical innovations, most devices that have been used in published trials are no longer manufactured and results of studies using newer endoscopic suturing systems are currently awaited. The duodenojejunal bypass sleeve mimics the physiology of intestinal bypass and shares the metabolic advantages of intestinal diversion. A high rate of premature device withdrawal has been its major limiting factor. Therapeutic endoscopy may be the next paradigm of bariatric care. Combining restrictive and barrier endoscopic techniques can potentially improve efficacy and should be evaluated in the setting of appropriate clinical trials.

Original languageEnglish (US)
Pages (from-to)2305-2311
Number of pages7
JournalSurgical Endoscopy and Other Interventional Techniques
Volume27
Issue number7
DOIs
StatePublished - Jul 1 2013
Externally publishedYes

Fingerprint

Obesity
Equipment and Supplies
Jejunoileal Bypass
Gastroplasty
Bariatrics
Bariatric Surgery
Endoscopy
Therapeutics
Clinical Trials
Safety
Gastroenterologists

Keywords

  • Bariatric endoscopy
  • Duodenojejunal bypass sleeve
  • Intragastric balloon
  • Obesity
  • Transoral gastroplasty

ASJC Scopus subject areas

  • Surgery

Cite this

A review of the current status of endoluminal therapy as a primary approach to obesity management. / Majumder, Shounak; Birk, John.

In: Surgical Endoscopy and Other Interventional Techniques, Vol. 27, No. 7, 01.07.2013, p. 2305-2311.

Research output: Contribution to journalReview article

@article{b182edddd6a7420a914345e93f59dc48,
title = "A review of the current status of endoluminal therapy as a primary approach to obesity management",
abstract = "Gastroenterologists are expected to play a pivotal role in the management of the global obesity epidemic in coming years as novel endoscopic approaches become more widely available, safe, and effective. This review focuses on the recent advances in the field of endoluminal therapy as a primary approach to obesity management with the aim of providing the interventional endoscopist an overview of currently available evidence along with an insight into upcoming devices and techniques. The intragastric balloon appears to be safe and effective in the short term, especially as a bridge to bariatric surgery. Although early trials support the safety and feasibility of endoscopic gastroplasty, it is technically demanding and staple-line dehiscence continues to be a problem. Moreover, with ongoing technical innovations, most devices that have been used in published trials are no longer manufactured and results of studies using newer endoscopic suturing systems are currently awaited. The duodenojejunal bypass sleeve mimics the physiology of intestinal bypass and shares the metabolic advantages of intestinal diversion. A high rate of premature device withdrawal has been its major limiting factor. Therapeutic endoscopy may be the next paradigm of bariatric care. Combining restrictive and barrier endoscopic techniques can potentially improve efficacy and should be evaluated in the setting of appropriate clinical trials.",
keywords = "Bariatric endoscopy, Duodenojejunal bypass sleeve, Intragastric balloon, Obesity, Transoral gastroplasty",
author = "Shounak Majumder and John Birk",
year = "2013",
month = "7",
day = "1",
doi = "10.1007/s00464-012-2765-7",
language = "English (US)",
volume = "27",
pages = "2305--2311",
journal = "Surgical Endoscopy",
issn = "0930-2794",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - A review of the current status of endoluminal therapy as a primary approach to obesity management

AU - Majumder, Shounak

AU - Birk, John

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Gastroenterologists are expected to play a pivotal role in the management of the global obesity epidemic in coming years as novel endoscopic approaches become more widely available, safe, and effective. This review focuses on the recent advances in the field of endoluminal therapy as a primary approach to obesity management with the aim of providing the interventional endoscopist an overview of currently available evidence along with an insight into upcoming devices and techniques. The intragastric balloon appears to be safe and effective in the short term, especially as a bridge to bariatric surgery. Although early trials support the safety and feasibility of endoscopic gastroplasty, it is technically demanding and staple-line dehiscence continues to be a problem. Moreover, with ongoing technical innovations, most devices that have been used in published trials are no longer manufactured and results of studies using newer endoscopic suturing systems are currently awaited. The duodenojejunal bypass sleeve mimics the physiology of intestinal bypass and shares the metabolic advantages of intestinal diversion. A high rate of premature device withdrawal has been its major limiting factor. Therapeutic endoscopy may be the next paradigm of bariatric care. Combining restrictive and barrier endoscopic techniques can potentially improve efficacy and should be evaluated in the setting of appropriate clinical trials.

AB - Gastroenterologists are expected to play a pivotal role in the management of the global obesity epidemic in coming years as novel endoscopic approaches become more widely available, safe, and effective. This review focuses on the recent advances in the field of endoluminal therapy as a primary approach to obesity management with the aim of providing the interventional endoscopist an overview of currently available evidence along with an insight into upcoming devices and techniques. The intragastric balloon appears to be safe and effective in the short term, especially as a bridge to bariatric surgery. Although early trials support the safety and feasibility of endoscopic gastroplasty, it is technically demanding and staple-line dehiscence continues to be a problem. Moreover, with ongoing technical innovations, most devices that have been used in published trials are no longer manufactured and results of studies using newer endoscopic suturing systems are currently awaited. The duodenojejunal bypass sleeve mimics the physiology of intestinal bypass and shares the metabolic advantages of intestinal diversion. A high rate of premature device withdrawal has been its major limiting factor. Therapeutic endoscopy may be the next paradigm of bariatric care. Combining restrictive and barrier endoscopic techniques can potentially improve efficacy and should be evaluated in the setting of appropriate clinical trials.

KW - Bariatric endoscopy

KW - Duodenojejunal bypass sleeve

KW - Intragastric balloon

KW - Obesity

KW - Transoral gastroplasty

UR - http://www.scopus.com/inward/record.url?scp=84884901204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884901204&partnerID=8YFLogxK

U2 - 10.1007/s00464-012-2765-7

DO - 10.1007/s00464-012-2765-7

M3 - Review article

C2 - 23344508

AN - SCOPUS:84884901204

VL - 27

SP - 2305

EP - 2311

JO - Surgical Endoscopy

JF - Surgical Endoscopy

SN - 0930-2794

IS - 7

ER -